Gururaja, Tarikere L

Abbv-101, a Highly Potent and Selective Clinical Stage Bruton Tyrosine Kinase Degrader for the Treatment of B-Cell Malignancies

Pan, C., Gururaja, T. L., Li, H., Nguyen, H., Zhai, Y., Xie, X., Ding, R.-X., Mathew, R., Hoh, H. Y., Jia, Z. J., et al. (2023) · Blood

Protein Degradation and InhibitorsChronic Lymphocytic Leukemia Research

Cited by 10